These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33963478)

  • 21. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
    Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
    Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
    Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
    Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China.
    Zhao Z; Shen J; Shen C; Zhu B; Sun J; Yu J; Sun F; Song H
    Curr Med Res Opin; 2021 Nov; 37(11):2001-2006. PubMed ID: 34376068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous Adverse Drug Reaction Monitoring in a Tertiary Care Centre.
    Kaur K; Kanwal P; Goyal P; Singh P; Yakhmi S; Jain S; Kaushal S
    Curr Drug Saf; 2020; 15(3):215-221. PubMed ID: 32735525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
    Adenuga BA; Kibuule D; Rennie TW
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety profile of methotrexate used off-label in ectopic pregnancy: an active monitoring study based on a Chinese hospital pharmacovigilance system.
    Wang L; Cai C; Huang L; Shi D; Chen Q; Chen Y; Yu W
    Curr Med Res Opin; 2024 Jan; 40(1):35-42. PubMed ID: 37975718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.
    Kröger E; Mouls M; Wilchesky M; Berkers M; Carmichael PH; van Marum R; Souverein P; Egberts T; Laroche ML
    Ann Pharmacother; 2015 Nov; 49(11):1197-206. PubMed ID: 26324356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of adverse drug reaction/adverse event and early warning signal mining of Ginkgo biloba Dropping Pills based on SRS data].
    Zhang C; Liu H; Xie YM; Wang Q
    Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2322-2328. PubMed ID: 32495588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal.
    Ribeiro-Vaz I; Santos C; da Costa-Pereira A; Cruz-Correia R
    Drug Saf; 2012 May; 35(5):387-94. PubMed ID: 22468615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxical adverse drug reactions: descriptive analysis of French reports.
    Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Italian monitoring registries: a tool for a safer use of innovative drugs? Data from the national pharmacovigilance system.
    Magro L; Arzenton E; Moretti U; Sottosanti L; Potenza S; Leone R
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):69-75. PubMed ID: 27875920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.
    Kane-Gill SL; Forsberg EA; Verrico MM; Handler SM
    Drug Saf; 2012 Aug; 35(8):645-53. PubMed ID: 22720659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse drug reaction reporting in institutions across six Chinese provinces: a cross-sectional study.
    Zhang X; Niu R; Feng B; Guo J; Liu Y; Liu X
    Expert Opin Drug Saf; 2019 Jan; 18(1):59-68. PubMed ID: 29883236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases.
    Machado-Alba JE; Londoño-Builes MJ; Echeverri-Cataño LF; Ochoa-Orozco SA
    Biomedica; 2016 Mar; 36(1):59-66. PubMed ID: 27622439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.